Cervical Pessary to Prevent Preterm Singleton Birth in High Risk Population
Launched by HOSPITAL SANT JOAN DE DEU · Oct 30, 2019
Trial Information
Current as of May 03, 2025
Unknown status
Keywords
ClinConnect Summary
Spontaneous preterm birth (sPB) is still a leading cause of neonatal and infant death and responsible of neonatal morbidity as cerebral palsy. In spite of improvements of neonatal care, rates of preterm birth have not changed in the recent 10 years.
Clinical risk factors for preterm birth include: 1) Demographic characteristics such a low socioeconomic status, poor antenatal care, malnutrition or extremes in maternal age; 2) Behavioral factors including smoking, illicit drug abuse, alcohol consumption or heavy physical work; 3) Obstetric history including uterine malformation, previous pre...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Singleton pregnancy.
- • Age \> 18 years old.
- • Gestational age between 18.0 -23.6 weeks of gestation.
- * Asymptomatic singleton pregnancies, with at least one of the following:
- • Previous spontaneous preterm delivery or PPROM (23 - 34.6 weeks).
- • Previous spontaneous second trimester miscarriage (16.0-22.6 weeks).
- • Previous surgery on uterine cervix.
- • Uterine malformation.
- • Able to sign informed consent form.
- Exclusion Criteria:
- • Congenital, chromosomal abnormalities or stillbirth in current pregnancy before randomization.
- • Women with an obstetrical history of iatrogenic preterm birth indicated for maternal or fetal conditions.
- • Symptomatic high-risk women or preterm prelabor rupture of membranes (PROM) in the current pregnancy.
- • Pregnant women with an indication of prophylactic cervical cerclage due to her own obstetrical history.
- • Pregnant women with an indication to perform a cervical cerclage, prior to study inclusion.
- • Cerclage in situ.
- • Active vaginal bleeding.
About Hospital Sant Joan De Deu
Hospital Sant Joan de Déu is a leading pediatric healthcare institution located in Barcelona, Spain, dedicated to providing comprehensive medical care and advanced research focused on children's health. Renowned for its commitment to innovation and excellence, the hospital actively participates in clinical trials to enhance treatment options and improve outcomes for pediatric patients. Leveraging a multidisciplinary approach, Hospital Sant Joan de Déu collaborates with various stakeholders, including academic institutions and industry partners, to advance medical knowledge and contribute to the development of groundbreaking therapies in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Patients applied
Trial Officials
Silvia Irene Ferrero Martínez, MD,PhD
Principal Investigator
BCNatal | Hospital Sant Joan de Déu - Hospital Clínic
Montse Palacio Riera, MD,PhD
Study Director
BCNatal | Hospital Clínic- Hospital Sant Joan de Déu
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials